1092467-10-1

Basic information

• Product Name: N-[2-hydroxy-2-(2,3-dihydrobenzo[β][1,4]dioxin-6-yl)-1-pyrrolidin-1-ylmethyl-ethyl]-3-(4-methoxy-phenoxy)-propionamide L-tartrate
• Synonyms: N-[2-hydroxy-2-(2,3-dihydrobenzo[β][1,4]dioxin-6-yl)-1-pyrrolidin-1-ylmethyl-ethyl]-3-(4-methoxy-phenoxy)-propionamide L-tartrate
• CAS NO: 1092467-10-1
• Molecular Weight: 606.627
• Mol File: 1092467-10-1.mol

Chemical Properties

• CAS DataBase Reference: N-[2-hydroxy-2-(2,3-dihydrobenzo[β][1,4]dioxin-6-yl)-1-pyrrolidin-1-ylmethyl-ethyl]-3-(4-methoxy-phenoxy)-propionamide L-tartrate(CAS DataBase Reference)
• NIST Chemistry Reference: N-[2-hydroxy-2-(2,3-dihydrobenzo[β][1,4]dioxin-6-yl)-1-pyrrolidin-1-ylmethyl-ethyl]-3-(4-methoxy-phenoxy)-propionamide L-tartrate(1092467-10-1)
• EPA Substance Registry System: N-[2-hydroxy-2-(2,3-dihydrobenzo[β][1,4]dioxin-6-yl)-1-pyrrolidin-1-ylmethyl-ethyl]-3-(4-methoxy-phenoxy)-propionamide L-tartrate(1092467-10-1)

Safety Data

• Hazardous Substances Data: 1092467-10-1(Hazardous Substances Data)

Upstream product

• 87-69-4 L-Tartaric acid 
• 956895-37-7 N-[2-hydroxy-2-(2,3-dihydrobenzo[β][1,4]dioxin-6-yl)-1-pyrrolidin-1-ylmethyl-ethyl]-3-(4-methoxy-phenoxy)-propionamide 
• 20811-60-3 3-(4-methoxyphenoxy)propanoic acid 
• 63815-39-4 2-(4-Methoxyphenoxy)cyanoethane 
• 150-76-5 4-methoxy-phenol 

Relevant articles and documents

Glucosylceramide synthase inhibition for the treatment of collapsing glomerulopathy and other glomerular disease

A method of treating a glomerular disease selected from the group consisting of mesangial proliferative glomerulonephritis, collapsing glomerulopathy, proliferative lupus nephritis, crescentic glomerulonephritis and membranous nephropathy in a subject com

2-ACYLAMINOPROPOANOL-TYPE GLUCOSYLCERAMIDE SYNTHASE INHIBITORS

A compound is represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises a compound represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof. A method of treating